| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.39B | +6.5% |
| Cost of Revenue | $2.08B | +3.2% |
| R&D Expense | $458.7M | +13.0% |
| SG&A Expense | $2.84B | +2.8% |
| Operating Income | $1.28B | +83.5% |
| Pre-tax Income | $1.07B | +164.5% |
| Income Tax | $42.2M | -62.4% |
| Net Income | $1.02B | +342.5% |
| EPS (Basic) | $4.91 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $415.8M | +10.7% |
| Accounts Receivable | $1.44B | +4.4% |
| Inventory | $2.39B | +11.1% |
| Current Assets | $4.61B | +4.1% |
| Total Assets | $21.50B | +2.0% |
| Current Liabilities | $2.86B | +21.2% |
| Long-term Debt | $1.00B | -80.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $291.1M | +54.9% |
| +346.4% |
| EPS (Diluted) | $4.88 | +343.6% |
| Total Liabilities |
| $9.01B |
| -0.3% |
| Stockholders' Equity | $12.48B | +3.8% |